CompoAtlas

PMK 083 Cold Sore Formula

Natural health product licensed in Canada

Other names
Cold Sore Formula
Licence holder
PMK Federal Regulatory Consultants Ltd.
NPN or DIN-HM
80033034
Status
Active licence
Licence date
22 June 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Lysine

Source : Monoacétate de L-lysine

500 mgNot calculated
L-Lysine

Source : Acétate de L-lysine

500 mgNot calculated
L-Lysine

Source : Chlorhydrate de L-lysine

500 mgNot calculated
L-Lysine

Source : L-Lysine dihydrochloride

500 mgNot calculated
L-Lysine

Source : Monochlorhydrate de L-lysine

500 mgNot calculated

Non-medicinal ingredients

Talc, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsuleminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Helps to reduce the recurrence of herpes simplex virus (HSV) infection (e.g. cold sores).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80033034

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line